Thank You for Attending the June Dialogue Series!
AsiaPac CXO Dialogue Series
 
WHERE CXOs CONNECT FOR HEALTH

What is the CXO Dialogue Series?

The HIMSS Aus CXO Dialogue Series is a strictly by-invitation only event that brings together C-Suite executives and industry leaders, to explore current and future developments in information and technology that will shape health and clinical outcomes, as well as policy in Australia and the respective states.

Following the success of the first series, the second HIMSS Aus CXO Dialogue Series will hone in on key issues raised by the country's healthcare leaders and explore strategies and directions that health IT leaders can take to reinvent capabilities in the face of digital transformation. 

Join us for a series of engaging conversations, debates and discussions that will enable your community to drive digital maturity within your organization, state and nation.   
Benefits of Attending:

Powerful networking with 20+ C-level and healthcare leaders at each dialogue

Australia’s healthcare IT market is expected to grow at a Compound Annual Growth Rate (CAGR) of 12.1% from 2015 to 2019. Learn about procurement plans

Gain insights on the latest eHealth Strategies. There is a lot happening in Australia!

eHealth Investments from Across Australia:
New South Wales: $536m investments in Digital Patient Records, Whole of System Digital Platform, Electronic Medication Management System and HealtheNet Pathology Results Repository. Queensland: Investing $300m for the "digital future", $100m for business systems and $730m for clinical systems. Victoria: Multiple eHealth services are investing in eHealth. Includes: Alfred Health, Monash Health, Grampians Rural Health Alliance, Gippsland Health Alliance all with budgets of between $4-$30m each for eHealth improvements. South Australia: More than $500m investments in health, including $442m on EPAS, $30m on Enterprise Pathology Laboratory Information System and ~$20m on Enterprise System for Medical Imaging.  Northern Territory: $259m investment in its core clinical systems renewal program.